Evaluation of One Burr Hole Evacuation for Subdural Hematoma
NCT ID: NCT06119932
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
35 participants
OBSERVATIONAL
2023-11-01
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Ultrasound in Diagnosis of Placenta Previa and MAP
NCT03416296
Outcomes of Surgical Treatment of Patients With Spinal Metastasis in AUH
NCT04110457
Management of Placenta Accreta Spectrum
NCT04609527
Endometrial Assessment of Women With Uterine Infection
NCT03824184
Intra-uterine Cleaning During Cesarean Section
NCT03398863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* one of the most frequent types of intracranial haemorrhage, That is still associated with significant morbidity (1.4.5).
* The SDH: is a common disease in elderly Patient, and Its Incidence is highest in persons older than 70 Years of age (1.5).
* Types of Subdural hematoma(18.19)
1- Acute: present within 48-72 hours of injury. 2. Sub-acute: manifest itself between 3-20 day. 3- Chronic (CH): produce symptoms from 3 weeks to several months after injury Risk Factors: (7.8.9.10.11.12)
1. Trauma; mostly minor Trauma, Approximately two thirds of The Patients have suffered one. Reports exist of chronic SDH due to birth trauma in neonates.
2. Advanced age: The elderly are at risk due to:
1. brain atrophy, whereby The bridging veins are stretched and become more fragile.
2. Older People tend to fall more often and Suffer minor head trauma.
3. With increase age, The incidence of blood Thinner administration raises leading to increased risk for haemorrhage
3. Chronic alcoholism:
4. Gender: men, from all age groups, suffer higher rates of chsDH than woman.
5. CoagulaPathy: Therapeutic anticoagulation and antiplatelet therapy.
6. Medical Conditions: sepsis, hepatic failure, hemophilia, DIC and renal dialysis.
7. Intracranial hypotension: as after ventriculoperitoneal shunt. clinical presentation (1.13)
* Symptoms of increase intra cranial pressure: Headache, Nausea, vomiting.
* Focal neurological deficit - (weakness, aphasia).
* Disturbed conscious level (DCL)
* Seizures
* Imaging investigation:
CT brain (14.15)
* Management : (1.6.16.17)
1. Conservative: A watch, wait and re-scan Policy is usually recommended in asymptomatic or minimally symptomatic patient with a thin CHSDH.
2. Surgical: For symptomatic (SDH) a- burr hole drainage B-twist drill drainage c- craniotomy
* prognostic factors : (2.5) 1- age of patient 2- Associated chronic diseases like hypertension, liver diseases …….Etc 3- Laboratory investigation like Hb , platlate count ,pc,and PT. 5- Hematoma thickness 6- number of burr hole : one or two burr hole
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evacuation for subdural hematoma by one burrhole
Evacuation for subdural hematoma by one burrhole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fit for surgery
* Chronic SDH
* Subacute SDH
* Age: patients older than 18 years old
* SEX: Both sex
Exclusion Criteria
* Acute SDH
* subdural hyroma
* subdural empyema
* patient treated conservatively
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammed lotfi abdelkareem
Neurosurgical resident
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shady Hassaan
Role: STUDY_DIRECTOR
Lecturer of Neurosurgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mohammed lotfi abdelkareem
Minya, Malawi, Egypt
Mohammed lotfi abdelkareem
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ahmed Abo kresha, Professor
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mohammed Lotfi a, Reseddnt
Role: primary
Mohammed Lotfi
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Subdural hematoma
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.